MAIA Biotechnology is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Vlad Vitoc, with a market cap of $79.5M.
Upcoming earnings announcement for MAIA Biotechnology
Past 12 earnings reports for MAIA Biotechnology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$0.08Est: -$0.13 | +38.5% | - | — | |
| Nov 7, 2025 | Q3 2025 | -$0.27Est: -$0.13 | -107.7% | - | — | |
| Aug 11, 2025 | Q2 2025 | -$0.18Est: -$0.21 | +14.3% | - | — | |
| May 9, 2025 | Q1 2025 | -$0.16Est: -$0.18 | +11.1% | - | — | |
| Mar 21, 2025 | Q4 2024 | -$0.12Est: -$0.35 | +65.7% | - | — | |
| Nov 12, 2024 | Q3 2024 | -$0.11 | — | - | — | |
| Aug 9, 2024 | Q2 2024 | -$0.40Est: -$0.39 | -2.6% | - | — | |
| May 14, 2024 | Q1 2024 | -$0.46Est: -$0.39 | -17.9% | - | — | |
| Mar 21, 2024 | Q4 2023 | -$0.41Est: -$0.39 | -5.1% | - | — | |
| Nov 7, 2023 | Q3 2023 | -$0.36Est: -$0.38 | +5.3% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.35Est: -$0.38 | +7.9% | - | — | |
| May 8, 2023 | Q1 2023 | -$0.38Est: -$0.40 | +5.0% | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.